BMJ editorial: Healthcare information for all (5) Access to information on vaccines

1 March, 2020

Thank you Neil, for your enormous and endless effort. I find that many resources are increasingly on different are being uploaded and shared in this blog on epidemiology, clinical features, prevention and containment on Corona Virus Disease. Contrary, not much is shared on treatment modalities and development of vaccines. Please highlight on these issues also in this blog [*see note below]. To develop, any effective vaccine suitable animal model, in which corona virus disease almost like human need to be introduced and further studies may be made. For, efficacy of treatment Randomized Control Trial need to be done among two groups of patient. Has there been any effort made in these areas?


Dr. Tusharkanti Dey

HIFA profile: Tusharkanti Dey is a Community Health Specialist at the Center for Total Development in India. Professional interests: Developing community health projects based on ICT. dr.tusharkantidey AT

[*Note from HIFA moderator (Neil PW): Thank you for this suggestion, Tusharkanti. Can anyone recommend an existing professional discussion forum on vaccines in general, or coronavirus in particular? In-depth discussion on vaccine development would be best handled on such a forum, with which HIFA could collaborate rather than duplicate. Gavi, the Vaccine Alliance, is ideally placed (and extremely well resourced) to promote professional discussion on specific issues relating to vaccine development and use. HIFA's key focus would be to look at who is providing information (and misinformation) on vaccines, and what needs to be done to improve the availability and use of reliable information. We have a few GAVI representatives on HIFA and I look forward to hear your thoughts on this subject.]